Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma
- PMID: 24682719
- DOI: 10.1245/s10434-014-3531-y
Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma
Abstract
Background: Aberrant Hedgehog (HH) signaling activation is important in cancer growth and mediates the interaction between cancer cells and the surrounding stromal cells. This study investigated the role of HH signaling on the growth of cholangiocarcinoma (CC), focusing on the interaction of CC cells with stromal cells.
Methods: To evaluate the interaction between human CC cells (SNU-1196, SNU-246, SNU-308, SNU-1079, and HuCCT-1) and stromal cells (hepatic stellate cell line, Lx-2), co-culture proliferation, migration, and invasion assays were performed. In vivo nude mice experiments were conducted using two groups-HuCCT-1 single implant xenograft (SX) and co-implant xenograft (CX) with HuCCT-1 and Lx-2.
Results: When HuCCT-1 cells were co-cultured with Lx-2 cells, the expression of HH signaling-related proteins increased in both HuCCT-1 and Lx-2 cells. Co-culture with Lx-2 cells stimulated the proliferation, migration, and invasion of CC cells, and these effects were mediated by HH signaling. Co-culture of HuCCT-1 and Lx-2 cells increased the secretion of several cytokines. In an ectopic xenograft model, Lx-2 co-implantation increased CC tumor growth and stimulated angiogenesis. Cyclopamine attenuated tumor growth in the CX group, but not in the HuCCT-1 mono-implant (SX) group. Cyclopamine treatment decreased CC cell proliferation, suppressed microvessel density, and increased tumor necrosis in the CX group, but not in the SX group.
Conclusion: Hepatic stellate cells stimulate the proliferation, migration, and invasion of CC cells, promote angiogenesis through HH signaling activation, and render CC more susceptible to necrosis by HH inhibitor.
Similar articles
-
Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.Ann Surg Oncol. 2011 Apr;18(4):1175-84. doi: 10.1245/s10434-010-1391-7. Epub 2010 Nov 2. Ann Surg Oncol. 2011. PMID: 21042948
-
Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.Ann Surg Oncol. 2009 Sep;16(9):2555-64. doi: 10.1245/s10434-009-0568-4. Epub 2009 Jun 23. Ann Surg Oncol. 2009. PMID: 19548033
-
Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.Hepatology. 2013 Mar;57(3):1035-45. doi: 10.1002/hep.26147. Epub 2013 Jan 25. Hepatology. 2013. PMID: 23172661
-
The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.Nat Rev Gastroenterol Hepatol. 2011 Nov 29;9(1):44-54. doi: 10.1038/nrgastro.2011.222. Nat Rev Gastroenterol Hepatol. 2011. PMID: 22143274 Review.
-
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma.Curr Opin Gastroenterol. 2011 May;27(3):276-84. doi: 10.1097/MOG.0b013e32834405c3. Curr Opin Gastroenterol. 2011. PMID: 21297470 Review.
Cited by
-
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma.Mol Cancer Ther. 2023 Mar 2;22(3):343-356. doi: 10.1158/1535-7163.MCT-22-0379. Mol Cancer Ther. 2023. PMID: 36807728 Free PMC article.
-
Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology.Rom J Morphol Embryol. 2020 Jul-Sep;61(3):615-642. doi: 10.47162/RJME.61.3.01. Rom J Morphol Embryol. 2020. PMID: 33817704 Free PMC article. Review.
-
The role of tumour microenvironment: a new vision for cholangiocarcinoma.J Cell Mol Med. 2019 Jan;23(1):59-69. doi: 10.1111/jcmm.13953. Epub 2018 Nov 5. J Cell Mol Med. 2019. PMID: 30394682 Free PMC article. Review.
-
Heterogeneity of Cholangiocarcinoma Immune Biology.Cells. 2023 Mar 8;12(6):846. doi: 10.3390/cells12060846. Cells. 2023. PMID: 36980187 Free PMC article. Review.
-
Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition.J Exp Clin Cancer Res. 2022 Nov 28;41(1):331. doi: 10.1186/s13046-022-02536-6. J Exp Clin Cancer Res. 2022. PMID: 36443822 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical